@ARTICLE{
author={Van Rhee Frits,Capra Marcelo,Wong Raymond,Vermeulen Jessica,Safer Karim,Todorovic Marija,Rhoten Patricia,Van de Velde Helgi},
year={2012},
title={Recruitment in a randomized, double-blind, placebo-controlled study to assess siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in patients with multicentric Castleman's disease.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={30},
number={15},
pages={-},
document_type={Meeting Abstract},
}